2015 annual financial data
Viridian Therapeutics 2015 Operating cash flow margin
Direct answer
Operating cash flow margin was -271.79%.
Operating income was -11,187,000 USD and net income was -11,328,000 USD.
Operating cash flow was -6,898,000 USD.
Get free Viridian Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 2,538,000 USD
- Operating income
- -11,187,000 USD
- Net income
- -11,328,000 USD
- Operating cash flow
- -6,898,000 USD